Herpes Simplex Virus
HSV shedding was detected in 2.4% of swabs during pritelivir treatment compared with 5.3% during valacyclovir treatment.
The USPSTF has released a final recommendation against routine serologic screening for genital herpes simplex virus infection.
A Grade D recommendation discourages routine screening in asymptomatic adolescents and adults.
Pericoital application of tenofovir gel, previously studied for HIV, linked to reduced risk of herpes infection.
Valacyclovir reduced HIV-1 levels in patients who did not have the herpes simplex virus 2.
Despite a less-than-robust efficacy profile, lysine supplementation is a safe and inexpensive remedy to try in patients with recurrent HSV outbreaks.
There were marked increases in the prevalence of HIV from 7% to 13% for nearly all demographic subgroups in two cohorts of noninjection drug users.
Oral tenofovir-based prophylaxis for HIV also reduced herpes simplex virus-2 transmission.
Dose-dependent reduction seen in rate of genital HSV shedding and days with lesions.
Herpes simplex virus reactivation likely accounts for disease transmission during therapy, prompting researchers to call for new treatments to successfully control and prevent onward HSV transmission.
A once-promising investigational vaccine against herpes viruses showed only 20% efficacy against herpes genital disease in a large clinical trial designed to mimic the general population of uninfected women.
Xerese is indicated for the early treatment of recurrent herpes labialis, to reduce the likelihood of ulcerative cold sores and to shorten the lesion-healing time in adults and adolescents.
People with herpes simplex virus type 2 that do not experience clinical signs and symptoms still shed the virus.
Can a person have mononucleosis more than once?
A 35-year-old white woman presented with grouped vesicles and superficial crusting on both lips and grouped erosions on the gingiva and hard palate.
A man presents with a six-month history of oral lesions that led to blistering and ulceration following intense sun exposure.
Consider genital herpes in the differential diagnosis of chronic dysuria.
What information do you have on resistance rates among antivirals for herpes simplex virus?
Which diagnostic test do you choose? Which treatment? What can you tell patients about recurrence? A dermatologist has the answers.
Numerous red target lesions develop on the extremities of a young woman being treated for acne.
Two women, the first bedridden with high fever and the second otherwise healthy, present with a vesicular rash.
The herpes zoster (shingles) vaccination is now recommended for people older than 60 years...